Related Experiment Videos
Antigen-presenting capacity in patients with sarcoidosis
1Second Department of Internal Medicine, Nagoya City University Medical School, Japan.
Chest
|October 1, 1990
Summary
Alveolar macrophages (AMs) from sarcoidosis patients, but not controls, showed enhanced antigen-presenting capacity to T-lymphocytes. This suggests AMs may contribute to T-lymphocyte activation in sarcoidosis.
Area of Science:
- Immunology
- Cell Biology
- Pulmonology
Background:
- Sarcoidosis is an inflammatory disease characterized by granuloma formation.
- The role of antigen-presenting cells (APCs) in sarcoidosis pathogenesis is not fully understood.
- Monocytes and alveolar macrophages (AMs) are key APCs.
Purpose of the Study:
- To investigate the antigen-presenting capacity of monocytes and AMs in patients with sarcoidosis compared to healthy controls.
- To explore the potential contribution of APCs to T-lymphocyte activation in sarcoidosis.
Main Methods:
- Antigen-presenting capacity was assessed using purified protein derivative (PPD) as the antigen.
- Monocytes and AMs were isolated from 13 sarcoidosis patients and 9 healthy controls.
- Capacity was tested against autologous peripheral and lung T-lymphocytes.
Main Results:
- Monocytes from both groups showed similar antigen-presenting capacity.
- AMs from sarcoidosis patients, unlike controls, demonstrated antigen-presenting capacity.
- Antigen presentation to lung T-lymphocytes was lower but not significantly different compared to peripheral T-lymphocytes.
Conclusions:
- Enhanced antigen-presenting capacity by AMs may contribute to T-lymphocyte activation in sarcoidosis.
- This enhanced capacity is not explained by increased DR antigen expression or IL-1/IFN-gamma release.
- Further research is needed to elucidate the precise mechanisms involved.